Aggregation Of Human Recombinant Monoclonal Antibodies

Human Hemoglobin Monoclonal Antibodies
MBS191460-3x01mg	MyBiosource	3x0.1mg	EUR 440

Human Monoclonal Laboratories manufactures the aggregation of human recombinant monoclonal antibodies reagents distributed by Genprice. The Aggregation Of Human Recombinant Monoclonal Antibodies reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact human monoclonal. Other Aggregation products are available in stock. Specificity: Aggregation Category: Of Group: Human Recombinant

Phenytoin Monoclonal Antibodies
MyBiosource	5x0.1mg	EUR 695

Phenobarbital Monoclonal Antibodies
MyBiosource	5x0.1mg	EUR 695

Quinidine Monoclonal Antibodies
MyBiosource	5x0.1mg	EUR 695

Lidocaine Monoclonal Antibodies
MyBiosource	5x0.1mg	EUR 695

Procainamide Monoclonal Antibodies
MyBiosource	7x0.1mg	EUR 955

Digoxin Monoclonal Antibodies
MyBiosource	3x0.1mg	EUR 440

Amitriptyline Monoclonal Antibodies
MyBiosource	2x0.1mg	EUR 310

Human Recombinant information

Aβ/tau aggregation-IN-1
T39781-50mg	TargetMol Chemicals	50mg	Ask for price

Description: Aβ/tau aggregation-IN-1

Aβ/tau aggregation-IN-1
T39781-5mg	TargetMol Chemicals	5mg	Ask for price

Description: Aβ/tau aggregation-IN-1

Aβ/tau aggregation-IN-1
HY-141661	MedChemExpress	10 mg	EUR 1839.86
Description: Aβ/tau aggregation-IN-1 is a potent Aβ1-42 β-sheets formation and tau aggregation inhibitor. The KD values of Aβ/tau aggregation-IN-1 with Aβ1-42 and tau are 160 μM and 337 μM, respectively. Aβ/tau aggregation-IN-1 can permeate the blood-brain barrier[1].

Aβ/tau aggregation-IN-3
HY-153430	MedChemExpress	10 mg	EUR 595.25
Description: Aβ/tau aggregation-IN-3 is a potent amyloid protein aggregation inhibitor with an IC50 of 0.85 μM by Aβ-Thioflavin T (Aβ-ThT) functional aggregation assay. Aβ/tau aggregation-IN-3 has anti-amyloid activity[1].

tau/Aβ40 aggregation-IN-1
HY-149272	MedChemExpress	Get quote	Ask for price
Description: tau/Aβ40 aggregation-IN-1 (Compound 20) is a tau and Aβ40 aggregation inhibitor with IC50s of 1.8 μM and 1.3 μM, respectively[1].

Abeta/tau aggregation-IN-1
MBS5800191-10mg	MyBiosource	10mg	EUR 590

Abeta/tau aggregation-IN-1
MBS5800191-25mg	MyBiosource	25(mg	EUR 1060

Abeta/tau aggregation-IN-1
MBS5800191-5mg	MyBiosource	5(mg	EUR 385

Aβ1–42 aggregation inhibitor 1
T64238-10mg	TargetMol Chemicals	10mg	Ask for price
Description: Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1
T64238-1g	TargetMol Chemicals	1g	Ask for price
Description: Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1
T64238-1mg	TargetMol Chemicals	1mg	Ask for price
Description: Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1
T64238-50mg	TargetMol Chemicals	50mg	Ask for price
Description: Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1
T64238-5mg	TargetMol Chemicals	5mg	Ask for price
Description: Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 2
HY-162093	MedChemExpress	Get quote	Ask for price
Description: Aβ1–42 aggregation inhibitor 2 (compound 7c) is a potent inhibitor of? Aβ1-42 aggregation that plays an important role in Alzheimer's disease research. Aβ1–42 aggregation inhibitor 2 displays excellent antioxidant, metal ions chelating, oxidative stress alleviation, neuroprotective and anti-neuroinflammatory activities[1].

Aβ1–42 aggregation inhibitor 1
HY-150003	MedChemExpress	Get quote	Ask for price
Description: Aβ1-42 aggregation inhibitor 1 inhibits AChE (acetylcholinesterase) and BuChE (butyrylcholinesterase) with the IC50 value of 2.64 μM and 1.29 μM, respectively. Aβ1-42 aggregation inhibitor 1 inhibits self-mediated Aβ1-42 aggregation by 51.29% at a concentration of 25 μM. Aβ1-42 aggregation inhibitor 1 has the potential for the research of anti-Alzheimer's disease[1].

Tau protein aggregation-IN-1
HY-153427	MedChemExpress	Get quote	Ask for price
Description: Tau protein aggregation-IN-1 (Compound 0c) is a Tau protein aggregation inhibitor. Tau protein aggregation-IN-1 can be used in the study of protein folding disorders such as Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease and prion-based spongiform encephalopathies[1].

Aggregation Factor, Geodia cydonium
MBS605823-001mg	MyBiosource	0.01mg	EUR 425

Apoptosis

Aggregation Of Human Recombinant Monoclonal Antibodies

Human Hemoglobin Monoclonal Antibodies

Phenytoin Monoclonal Antibodies

Phenobarbital Monoclonal Antibodies

Quinidine Monoclonal Antibodies

Lidocaine Monoclonal Antibodies

Procainamide Monoclonal Antibodies

Digoxin Monoclonal Antibodies

Amitriptyline Monoclonal Antibodies

Aβ/tau aggregation-IN-1

Aβ/tau aggregation-IN-1

Aβ/tau aggregation-IN-1

Aβ/tau aggregation-IN-3

tau/Aβ40 aggregation-IN-1

Abeta/tau aggregation-IN-1

Abeta/tau aggregation-IN-1

Abeta/tau aggregation-IN-1

Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 1

Aβ1–42 aggregation inhibitor 2

Aβ1–42 aggregation inhibitor 1

Tau protein aggregation-IN-1

Aggregation Factor, Geodia cydonium

A nice attention grabbing header!